Price Chart

Headline
Wire
Time (ET)
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/03/2023 08:00 EST Earnings Call Q1 2023 -- -- --
02/03/2023 -- Results Q1 2023 -- -- --
11/18/2022 08:00 EST Earnings Call Q4 2022 -- -- --
11/18/2022 -- Results Q4 2022 -1.01 -1.14 10.91%
08/05/2022 08:00 EST Earnings Call Q3 2022 -- -- --
08/05/2022 -- Results Q3 2022 -1.08 -1.31 17.40%
05/05/2022 16:30 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q2 2022 -1.02 -1.30 21.57%
*Estimated Date/Time

Earnings

Next Report Date 02/03/2023
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/18/2022
Beat/Miss Upgrade
Return Since 17.49%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
URL https://www.twistbioscience.com
Investor Relations URL https://investors.twistbioscience.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Growth
Next Earnings Release Feb. 03, 2023
Last Earnings Release Nov. 18, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
--
--
--
-9.05%
572.8%
-45.23%
-69.23%
22.43%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
6.11%
-38.13%
-31.16%
-24.87%
108.1%
-27.93%
-13.82%
-36.28%
21.13%
-78.57%
4.09%
-76.55%
-0.62%
-24.70%
-53.18%
17.86%
3.79%
-47.58%
48.46%
17.10%
-95.00%
-57.48%
77.60%
-68.73%
139.1%
--
--
--
-85.79%
-73.70%
-79.00%
-92.45%
-44.48%
As of January 27, 2023.

Profile

Edit
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
URL https://www.twistbioscience.com
Investor Relations URL https://investors.twistbioscience.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Growth
Next Earnings Release Feb. 03, 2023
Last Earnings Release Nov. 18, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
ARKG 77.73M USD 3.52%
IDNA 4.731M USD 2.83%
EDOC 3.422M USD 2.27%
JSCGX 158580.0 USD 1.93%
F00001ER05 188.00 USD 1.88%
ADNRX 3.477M USD 1.46%
ARKK 107.09M USD 1.46%
XBI 83.17M USD 1.03%
LABU 7.401M USD 0.67%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter TWST Tweets